Predictive factors for successful weaning from mechanical ventilation in the internal medicine department.

Publication date: Feb 05, 2025

The aging of the Israeli population along with a shortage of ICU beds have led to hospitalization of invasive mechanical ventilation patients in internal medicine departments, where, as opposed to ICU, the treatment is less than optimal. The aims of the study were to evaluate the predictive factors for successful weaning from mechanical ventilation in ventilated patients admitted to internal medicine departments. A retrospective study that included non-COVID 19 ventilated patients in internal medicine departments in a university affiliated hospital in Israel between the years 2018-2019. We compared datapoints between patients who were weaned from ventilators versus those who remained ventilated during the hospitalization, and defined demographic and clinical predictive factors for successful weaning. Data were collected from electronic medical records and included demographic, clinical, laboratory and ventilator information. The study group included 348 patients. The rate of successful weaning was 19%; patients who were successfully weaned were primarily functionally independent prior to ventilation, ventilated with low PEEP values, had high hemoglobin and albumin levels alongside with low CRP and lactate levels. Those who remained ventilated either required vasopressor treatment, had positive blood cultures or had lower GFR levels. The overall in-hospital mortality rate was 60%, while the 30-day mortality rate was lower in the extubated group [214 (76%) vs. 6 (9%), P 

Open Access PDF

Concepts Keywords
Hospitalization Internal medicine departments
Israel Mechanical ventilation
Laboratory Predictive factors
Successful Weaning

Semantics

Type Source Name
disease MESH weaning
disease MESH COVID 19
disease IDO blood
disease MESH Emergency
drug DRUGBANK Etoperidone
disease MESH morbidity
disease IDO history
disease MESH cognitive impairment
disease MESH muscle atrophy
disease MESH contraindication
drug DRUGBANK Spinosad
disease MESH infection
disease MESH functional status
disease MESH hypertension
disease MESH diabetes mellitus
disease MESH congestive heart failure
disease MESH chronic renal failure
drug DRUGBANK Corticorelin
disease MESH stroke
disease MESH COPD
disease MESH malignancy
disease MESH liver cirrhosis
disease MESH bleeding
drug DRUGBANK Creatinine
drug DRUGBANK Coenzyme M
disease MESH Asthma
pathway KEGG Asthma
drug DRUGBANK Pantoprazole
disease MESH multiple organ dysfunction syndrome
disease MESH complications
drug DRUGBANK Trestolone
disease MESH pneumonia
drug DRUGBANK Human Serum Albumin
drug DRUGBANK Dopamine
disease MESH septic shock
disease MESH causes
disease MESH sepsis
disease IDO process
pathway REACTOME Reproduction
drug DRUGBANK Alpha-Linolenic Acid
drug DRUGBANK Guanosine

Original Article

(Visited 1 times, 1 visits today)